iShares Morningstar Small-Cap ETF news

The ETF is presented as a sufficient option with positive attributes (low costs, diversification, solid performance of 16.7% YTD), but receives a Hold rating rather than a Buy recommendation, indicating it is adequate but not exceptional.

Established fund with strong long-term track record (8.35% annualized since 2004), ultra-low expense ratio (0.04%), broader diversification (1,557 holdings), and higher dividend yield (1.30%). Positioned as solid alternative despite underperforming BBSC recently.

ISCB is presented as a solid alternative with nearly identical low costs (0.04% expense ratio) and slightly higher dividend yield (1.27%), but underperforms VB with lower annualized returns (8.9% since 2004) and significantly smaller AUM ($277.7M), creating higher liquidation risk.

ISCB offers broader diversification with 1,544 holdings, slightly higher dividend yield (1.30%), and stronger 1-year performance (31.60%). However, it has higher maximum drawdown (29.90% vs 28.20%) and lower AUM ($286.2M), making it more suitable for income-focused investors willing to accept higher volatility.

Offers lowest expense ratio at 0.04%, broader diversification with 1,548 holdings, slightly higher dividend yield (1.3%), and lower cost entry point. Better suited for investors prioritizing diversification and cost efficiency, though with higher volatility (max drawdown of 29.9%) due to inclusion of unprofitable companies.

ISCB offers identical low fees, slightly higher dividend yield (1.3% vs 1.1%), and marginally lower historical drawdown (-29.94% vs -30.78%). However, it significantly underperformed SCHA on returns and has much smaller assets ($268.5M), limiting liquidity. The healthcare/industrials tilt provides portfolio balance but doesn't offer structural advantages.